Oncology Research

HeraBioLabs | Ramesh Narayanan

Jack Crawford2023-03-01T07:26:07+00:00

HeraBioLabs | Goutham Narla

Jack Crawford2023-03-01T07:25:50+00:00

HeraBioLabs | Fallon Noto

Jack Crawford2023-03-01T07:26:47+00:00

Overcoming translational barriers by using the SRG Rat: case studies with the OncoRat®

Jack Crawford2023-03-01T07:27:23+00:00

The OncoRat – Three experts describe their experience

Jack Crawford2023-03-01T07:27:53+00:00

Fine Needle Aspirate Serial Tumor Sampling Services To Boost Your Xenograft Study Capabilities

Precision Toxicology and Efficacy News, Insightful Insights

Fine Needle Aspirate Serial Tumor Sampling Services To Boost Your Xenograft Study Capabilities

Xenograft tumors from human cancer cell lines in immunocompromised mice are [...]

Hera Admin2022-02-24T18:09:30+00:00

Validation Of The SRG Rat For Human Tumor Studies Published In PLOS ONE

Precision Toxicology and Efficacy News, Insightful Insights

Validation Of The SRG Rat For Human Tumor Studies Published In PLOS ONE

We Are Excited To Announce That A Validation Study Using [...]

Jack Crawford2022-02-15T22:17:52+00:00

786-O renal cell carcinoma tumor model

VALIDATED CELL LINE 786-O Renal Cell Carcinoma [...]

Hera Admin2024-11-02T16:48:35+00:00

The SRG rat, a Sprague-Dawley Rag2/Il2rg double-knockout validated for human tumor oncology studies

Kristina Celin2025-03-17T18:45:23+00:00

OncoRat® Featured In Clinical Cancer Research For Prostate Cancer Studies

Precision Toxicology and Efficacy News, Insightful Insights

OncoRat® Featured In Clinical Cancer Research For Prostate Cancer Studies

Improving Preclinical Anticancer Studies Using Rat Xenograft Model Systems: A Case [...]

Jack Crawford2022-02-15T22:27:31+00:00Tags: Cell Line Xenografts, preclinical, oncology models, Hera Biolabs, Cancer, rat model, drug discovery, OncoRat, Oncology, Xenografts, in vivo model, Cancer Xenografts, Immunodeficient Rats, NSG Mice, Clincal Cancer Research|

Previous 789 Next

Title